SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-074970
Filing Date
2019-03-14
Accepted
2019-03-14 17:14:08
Documents
4
Effectiveness Date
2019-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 d689742ds8.htm S-8 50164
2 EX-5.1 d689742dex51.htm EX-5.1 6966
3 EX-23.2 d689742dex232.htm EX-23.2 1357
4 GRAPHIC g689742g56x96.jpg GRAPHIC 3162
  Complete submission text file 0001193125-19-074970.txt   64040
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230287 | Film No.: 19681899
SIC: 2836 Biological Products, (No Diagnostic Substances)